Nina Niu Sanford/utswmed.org
May 6, 2025, 10:56
Nina Niu Sanford: RT use in Pancreatic Cancer in Europe
Nina Niu Sanford, Assistant Professor and Chief of Gastrointestinal Radiation Oncology at Harvard/Brigham and Women’s Hospital/Massachusetts General Hospital, shared a post on X:
“Survey re: RT use in pancreas cancer in Europe.
Like US, practice patterns vary widely- LAPC s/p chemo: 42% chemoRT, 23% SBRT, 35% chemo alone.
If at NRG credentialed site in Europe & interested in enrolling in LAP100 (Ph III RCT of dose-escalated RT in LAPC), let me know!”
More posts featuring Pancreatic Cancer on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 6, 2025, 10:56
May 6, 2025, 10:48
May 6, 2025, 10:47
May 6, 2025, 10:46
May 6, 2025, 10:37
May 6, 2025, 10:33
May 6, 2025, 10:31
May 6, 2025, 10:19